Alzheimer's Disease - Alliance for Patient Access

ICER's Alzheimer's Disease Review

For questions or to get involved email Casey McPherson at [email protected].

Q & A

Featured Speakers

David Charles, MD, Co-Founder and CMO, Alliance for Patient Access
Josie Cooper, Executive Director, Alliance for Patient Access
Adina Lasser, Public Policy Manager, Alliance for Aging Research
Jay Reinstein, Patient Advocate
Michelle Winokur, Executive Director, Institute for Patient Access

Learn more about the speakers here.

Featured Resources

Elevating the Experiences of Schizophrenia Patients & Providers

Institute for Patient Access

Learn More >

Societal Costs of Schizophrenia & Related Diseases

Schizophrenia & Psychosis Action Alliance

Learn More >

Reimagine Schizophrenia: Transforming How We Are Treated, Function and Thrive

Schizophrenia & Psychosis Action Alliance

Learn More >

Supporting Patients with Serious Mental Illness

Alliance for Patient Access

Learn More >

ICER’s Hasty Analysis of New Schizophrenia Treatment

Health Policy Today

Learn More >

ICER Lowballs Critical Alzheimer's Medications

Institute for Patient Access

Amplifying the Voices of Alzheimer's: ICER Toolkit

Institute for Patient Access

Learn More >

Who Will Control Access to New Alzheimer’s Treatments?

Health Policy Today

Learn More >

Preventing Alzheimer’s Disease By 2025

Health Policy Today

Learn More >

Why Health Care Providers Should Care About ICER

Institute for Patient Access

Learn More >

What's Wrong With ICER?

Institute for Patient Access

Learn More >

What is ICER?

Alliance for Aging Research

Learn More >

ICER and Cost-Effective Health Care

Alliance for Aging Research

Learn More >

What you need to know about ICER

Alliance for Aging Research

Learn More >

Assessing the Value of Therapies in Alzheimer’s Disease

Alliance for Aging Research

Learn More >